These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21966889)

  • 1. Discovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu(4)) with oral efficacy in an antiparkinsonian animal model.
    Jones CK; Engers DW; Thompson AD; Field JR; Blobaum AL; Lindsley SR; Zhou Y; Gogliotti RD; Jadhav S; Zamorano R; Bogenpohl J; Smith Y; Morrison R; Daniels JS; Weaver CD; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2011 Nov; 54(21):7639-47. PubMed ID: 21966889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
    Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
    ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
    Jones CK; Bubser M; Thompson AD; Dickerson JW; Turle-Lorenzo N; Amalric M; Blobaum AL; Bridges TM; Morrison RD; Jadhav S; Engers DW; Italiano K; Bode J; Daniels JS; Lindsley CW; Hopkins CR; Conn PJ; Niswender CM
    J Pharmacol Exp Ther; 2012 Feb; 340(2):404-21. PubMed ID: 22088953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4).
    Gogliotti RD; Blobaum AL; Morrison RM; Daniels JS; Salovich JM; Cheung YY; Rodriguez AL; Loch MT; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    Bioorg Med Chem Lett; 2016 Jul; 26(13):2984-2987. PubMed ID: 27234146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats.
    Engers DW; Field JR; Le U; Zhou Y; Bolinger JD; Zamorano R; Blobaum AL; Jones CK; Jadhav S; Weaver CD; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2011 Feb; 54(4):1106-10. PubMed ID: 21247167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
    Niswender CM; Johnson KA; Weaver CD; Jones CK; Xiang Z; Luo Q; Rodriguez AL; Marlo JE; de Paulis T; Thompson AD; Days EL; Nalywajko T; Austin CA; Williams MB; Ayala JE; Williams R; Lindsley CW; Conn PJ
    Mol Pharmacol; 2008 Nov; 74(5):1345-58. PubMed ID: 18664603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, Structure-Activity Relationship, and Antiparkinsonian Effect of a Potent and Brain-Penetrant Chemical Series of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4.
    Charvin D; Pomel V; Ortiz M; Frauli M; Scheffler S; Steinberg E; Baron L; Deshons L; Rudigier R; Thiarc D; Morice C; Manteau B; Mayer S; Graham D; Giethlen B; Brugger N; Hédou G; Conquet F; Schann S
    J Med Chem; 2017 Oct; 60(20):8515-8537. PubMed ID: 28902994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one.
    Satow A; Suzuki G; Maehara S; Hikichi H; Murai T; Murai T; Kawagoe-Takaki H; Hata M; Ito S; Ozaki S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2009 Jul; 330(1):179-90. PubMed ID: 19359526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy.
    Slee DH; Zhang X; Moorjani M; Lin E; Lanier MC; Chen Y; Rueter JK; Lechner SM; Markison S; Malany S; Joswig T; Santos M; Gross RS; Williams JP; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Wen J; O'Brien Z; Saunders J
    J Med Chem; 2008 Feb; 51(3):400-6. PubMed ID: 18189346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
    Bennouar KE; Uberti MA; Melon C; Bacolod MD; Jimenez HN; Cajina M; Kerkerian-Le Goff L; Doller D; Gubellini P
    Neuropharmacology; 2013 Mar; 66():158-69. PubMed ID: 22491024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction.
    East SP; Bamford S; Dietz MG; Eickmeier C; Flegg A; Ferger B; Gemkow MJ; Heilker R; Hengerer B; Kotey A; Loke P; Schänzle G; Schubert HD; Scott J; Whittaker M; Williams M; Zawadzki P; Gerlach K
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4901-5. PubMed ID: 20638279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo.
    Lindsley CW; Wisnoski DD; Leister WH; O'brien JA; Lemaire W; Williams DL; Burno M; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Duggan ME; Hartman GD; Conn PJ; Huff JR
    J Med Chem; 2004 Nov; 47(24):5825-8. PubMed ID: 15537338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
    Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
    J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.
    Johnson KA; Jones CK; Tantawy MN; Bubser M; Marvanova M; Ansari MS; Baldwin RM; Conn PJ; Niswender CM
    Neuropharmacology; 2013 Mar; 66():187-95. PubMed ID: 22546615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
    Iderberg H; Maslava N; Thompson AD; Bubser M; Niswender CM; Hopkins CR; Lindsley CW; Conn PJ; Jones CK; Cenci MA
    Neuropharmacology; 2015 Aug; 95():121-9. PubMed ID: 25749357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and optimization of a novel CNS penetrant series of mGlu
    Kent CN; Fulton MG; Stillwell KJ; Dickerson JW; Loch MT; Rodriguez AL; Blobaum AL; Boutaud O; Rook JL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2021 Apr; 37():127838. PubMed ID: 33556572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5.
    Zysk JR; Spear N; Fieles W; Stein MM; Sygowski LS; King MM; Hoesch V; Hastings R; Brockel B; Do M; Ström P; Gadient R; Chhajlani V; Elmore CS; Maier DL
    Synapse; 2013 Mar; 67(3):135-44. PubMed ID: 23150216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally active metabotropic glutamate subtype 2 receptor positive allosteric modulators: structure-activity relationships and assessment in a rat model of nicotine dependence.
    Sidique S; Dhanya RP; Sheffler DJ; Nickols HH; Yang L; Dahl R; Mangravita-Novo A; Smith LH; D'Souza MS; Semenova S; Conn PJ; Markou A; Cosford ND
    J Med Chem; 2012 Nov; 55(22):9434-45. PubMed ID: 23009245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu
    Bollinger SR; Engers DW; Panarese JD; West M; Engers JL; Loch MT; Rodriguez AL; Blobaum AL; Jones CK; Thompson Gray A; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2019 Jan; 62(1):342-358. PubMed ID: 30247901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.
    Goudet C; Vilar B; Courtiol T; Deltheil T; Bessiron T; Brabet I; Oueslati N; Rigault D; Bertrand HO; McLean H; Daniel H; Amalric M; Acher F; Pin JP
    FASEB J; 2012 Apr; 26(4):1682-93. PubMed ID: 22223752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.